XTL Biopharmaceuticals Ltd ADR (XTLB) — Net Asset Momentum
XTL Biopharmaceuticals Ltd ADR (XTLB) recorded a net asset momentum of 144.8% as of December 2024, with net assets of $5.43 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See XTLB book value for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
XTL Biopharmaceuticals Ltd ADR Net Asset Momentum (2002–2024)
This chart tracks XTL Biopharmaceuticals Ltd ADR's year-over-year net asset growth across 23 annual reporting periods from 2002 to 2024. The most recent momentum reading is +144.8%, with net assets of $5.43 Million USD as of December 2024. For live market cap and overall valuation, see XTLB market cap.
Annual Net Asset History for XTL Biopharmaceuticals Ltd ADR (2002–2024)
The table below shows the complete annual net asset history for XTL Biopharmaceuticals Ltd ADR from 2002 to 2024, covering 23 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check XTL Biopharmaceuticals Ltd ADR (XTLB) tangible net worth to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $5.43 Million | $8.55 Million | $3.12 Million | ▲ +144.8% |
| 2023 | $2.22 Million | $2.43 Million | $206.00K | ▼ -44.5% |
| 2022 | $4.00 Million | $4.19 Million | $187.00K | ▼ -25.0% |
| 2021 | $5.33 Million | $6.62 Million | $1.28 Million | ▼ -14.7% |
| 2020 | $6.25 Million | $6.50 Million | $254.00K | ▼ -10.5% |
| 2019 | $6.98 Million | $7.21 Million | $232.00K | ▼ -16.1% |
| 2018 | $8.32 Million | $8.57 Million | $253.00K | ▲ +130.0% |
| 2017 | $3.62 Million | $6.59 Million | $2.97 Million | ▲ +34.7% |
| 2016 | $2.69 Million | $3.02 Million | $330.00K | ▼ -45.0% |
| 2015 | $4.89 Million | $5.32 Million | $436.00K | ▲ +4.4% |
| 2014 | $4.68 Million | $5.64 Million | $965.00K | ▼ -31.0% |
| 2013 | $6.79 Million | $8.02 Million | $1.23 Million | ▼ -28.0% |
| 2012 | $9.42 Million | $11.09 Million | $1.66 Million | ▲ +173.6% |
| 2011 | $3.44 Million | $4.07 Million | $629.00K | ▲ +21.5% |
| 2010 | $2.83 Million | $3.80 Million | $963.00K | ▲ +40385.7% |
| 2009 | $7.00K | $715.00K | $708.00K | ▼ -99.5% |
| 2008 | $1.43 Million | $3.43 Million | $2.00 Million | ▼ -83.3% |
| 2007 | $8.56 Million | $14.13 Million | $5.56 Million | ▼ -62.4% |
| 2006 | $22.76 Million | $26.90 Million | $4.14 Million | ▲ +102.3% |
| 2005 | $11.25 Million | $15.15 Million | $3.90 Million | ▼ -42.6% |
| 2004 | $19.60 Million | $25.62 Million | $6.02 Million | ▼ -4.9% |
| 2003 | $20.61 Million | $24.85 Million | $4.25 Million | ▼ -40.8% |
| 2002 | $34.83 Million | $38.42 Million | $3.59 Million | — |